비씨월드제약

200780KOSDAQ

52.8 / 100

Reference Date: 2026-09-08

Financial Score20.0 / 40

News Sentiment18.8 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly down 2.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

BC World Pharm focuses on R&D of new and improved drugs, maintaining competitiveness in both domestic and international markets by exporting specialty pharmaceuticals produced in facilities compliant with FDA and EMA standards. The company is expanding its CMO/CDMO business and pursuing overseas licensing deals, addressing growing pharmaceutical demand driven by aging populations.

Number of Employees

288people

Average Salary

40.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.45Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

-4.23Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

20.12Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲0.5% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼21.7% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -1.6% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 1Neutral 0Negative 1Average Sentiment Score 75

Negative
"버는 돈보다 이자가 더 많다"…'좀비기업' 문턱 선 제약사 [종목+]
비씨월드제약의 높은 차입금 비율과 이자보상배율 저하로 인해 재무적 어려움이 예상됨.
Positive
비씨월드제약, 정부 연구개발 과제 최종 선정…AI기반 항생제 내성 대....
비씨월드제약이 AI 기반 항생제 내성 대응 신약 개발로 정부 지원을 받게 되어 긍정적인 투자 전망을 보임.

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 3,030Won52-week high 5,87052-week low 2,960

1-month return2.0Point

1m -2.73% (slight drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-13